NewsRx

Search our medical news database

Epilepsy

Medicare reimbursement rates posted for VNS therapy

Published in Medical Letter on the CDC and FDA, December 7th, 2003

Cyberonics, Inc., (CYBX) announced that 2004 Medicare outpatient reimbursement rates for Cyberonics' VNS Therapy System were posted on the CMS website and were published in the Federal Register.

Beginning January 2004, Medicare will reimburse hospitals on average a total of approximately $24,071 for the outpatient implantation and intra-operative programming of VNS Therapy Systems as follows: $12,832 under new APC 0039 for implantation of neurostimulator and $11,239 under existing APC 0225 for implantation of neurostimulator electrodes. In 2003, Medicare reimbursed hospitals on average of a total of approximately $19,500 for outpatient implantation of the VNS...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook